Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Site details revised
  2. Start date: Aug 2026 to Oct 2026
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 2 of 5 entries
    • Study description revised
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This is an investigator-initiated cluster randomized control trial. The primary objective is to compare the diagnostic yield of two Food and Drug Administration (FDA) cleared national robotic assisted bronchoscopy platforms - the Monarch™ Platform and the ION™ Endoluminal System - in participants undergoing bronchoscopy to evaluate peripheral pulmonary lesions (PPLs). Participants will undergo their scheduled robotic assisted bronchoscopy (RAB) using one of these platforms.
Trial Details
NCT Number NCT07735611
Lead Sponsor Case Comprehensive Cancer Center
Conditions
(from sponsor)		 Lung; Node
Enrollment 398 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov